Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
8 Hits
Search Condition : Filter (MeSH = Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
K562
72426
Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia.
J Pharmacol Sci
2021-9-1
Pubmed
Full text
Human and Animal Cells
K562
60001
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
Int J Oncol
2019-5-1
Pubmed
Full text
Human and Animal Cells
EoL-1 cell(RCB0641)
55966
miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
Exp Hematol
2018-12-1
Pubmed
Full text
Human and Animal Cells
K562
42216
Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid.
Anticancer Res
2004-1-1
Pubmed
Human and Animal Cells
38548
Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562.
Invest New Drugs
2012-6-1
Pubmed
Full text
Human and Animal Cells
38546
Liquid crystal-related compound-induced cell growth suppression and apoptosis in the chronic myelogenous leukemia K562 cell line.
Invest New Drugs
2011-10-1
Pubmed
Full text
Human and Animal Cells
EoL-1 cell(RCB0641)
18976
Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene.
Leukemia
2010-9-1
Pubmed
Full text
Mice
RBRC01071
6070
Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
Nature
2010-8-5
Pubmed
Full text